Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 9, 2002, Pages 493-496

  Mochizuki, Fumiro ^a   Fujii, Masashi ^a   Kasakura, Yuichi ^a   Yamagata, Motoo ^a   Kochi, Mitsugu ^a   Wakabayashi, Kazuhiko ^a   Kanamori, Noriaki ^a   Takayama, Tadatoshi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

5 FU; CDDP; ETP; Gastric cancer; LV

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; LEUKOPENIA; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LEUKOPENIA; MALE; MIDDLE AGED; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0036380371     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0369-7     Document Type: Article

References (25)

1. Aigner KR, Benthin F, Muller H (1991) Celiac axis infusion (CAI) chemotherapy for advanced gastric cancer. Cancer Treat Res 55:357-362
2. Ajani JA, Ota DM, Jessep JM, Ames FC, McBride C, Levin B, Jackson DE, Roh M, Hohn D (1991) Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer 68:1501-1506
3. Ajani JA, Fairweather J, Dumas P, Patt YZ, Pazdur R, Mansfield PF (1998) Phase II study of Taxol in patients with advanced gastric carcinoma. Cancer J Sci Am 4:269-274
4. Chung YS, Yamashita Y, Inoue T, Matsuoka T, Nakata B, Onda N, Maeda K, Sawada T, Kato Y, Shirasaka T, Sowa M (1997) Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma. Cancer 80:1-7
5. Findlay M, Cunningham D (1993) Chemotherapy of carcinoma of stomach. Cancer Treat Rev 19:29-44
6. Glimelius B, Hoffman K, Haglund V, Nyren O, Sjoeden PO (1994) Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol 5:189-190
7. Hashimoto T, Omura K, Ishida F, Watanabe Y (1993) Clinical eLcacy of cis-diamminedichloroplatinum (II) and 5-fluorouracil (UFT) in advanced cancer of the alimentary tract. Jpn J Cancer Chemother 20:1333-1338
8. Japanese Gastric Cancer Association (2001) Japanese classification of gastric carcinoma - response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria. 2nd English edn. Gastric Cancer 4:1-8
9. Kerr DJ (1989) 5-fluorouracil and folinic acid: interesting biochemistry of eIective treatment? Br J Cancer 60:807-808
10. Lacave AJ, Baron FJ, Anton LM, Estrada E, De Sande LMG, Palacio I, Esteban E, Garcia JM, Buesa JM, Fernandez OA, Baron MG (1991) Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: a phase II trial. Ann Oncol 2:751-754
11. Lerner A, Gonin R, Steele GD Jr, Mayer RJ (1992) Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: Results of a phase II trial. J Clin Oncol 10:536-540
12. Matsukura N, Onda M, Tokunaga A, Teramoto T, Fujita I, Okuda T, Miyashita M, Okazaki S, Arima Y, Yamashita K (1994) Therapeutic eIect of combination chemotherapy with 5-fluorouracil (5-FU) and cis-diamminedichloroplatinum (CDDP) in advanced and recurrent gastric cancer. J Jpn Soc Cancer Ther 29:841-848
13. Mochizuki F, Fujii M, Kasakura Y, Kanamori N, Kochi M, Tani M, Otsuka Y, Yamagata M, Iwai S (1997) Clinical analysis of combination chemotherapy for advanced and recurrent gastric cancer with 5-fluorouracil (5-FU) and cis-diamminedichloroplatinum (CDDP). In: Progress in gastric cancer research. Monduzzi, Bologna, pp 1559-1563
14. Mochizuki F, Fujii M, Kasakura Y, Yamagata M, Kochi M, Wakabayashi K, Asaki H, Iwai S (2000) A phase II study of combination chemotherapy for advanced and recurrent gastric cancer with low-dose cis-diamminedichloroplatinum (CDDP) and 5-fluorouracil (5-FU). Nihon Univ J Med 42:191-202
15. Murad AM, Santiago FF, Petroiam A, Rocha PRS, Rodrigues MAG, Rausch M (1993) Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. 72:37-41
16. Nakajima T, Ota K, Ishihara S, Oyama S, Nishi M, Ohashi Y, Yanagisawa A (1997) Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol 4:203-208
17. National Cancer Institute (1999) Common toxicity criteria. Jpn J Cancer Chemother 26:1085-1144
18. O'Connell MJ (1989) A phase III trial of 5-fluorouracil and leucovorin in the treatment of colorectal cancer. Cancer 63:1026-1030
19. Ohtsu A, Yoshida S, Saito D, Shimada Y, Miyamoto K, Takahiro F, Yoshino M, Yoshimori, M (1991) An early phase II study of 5-fluorouracil combined with cisplatinum as a second line chemotherapy against metastatic gastric cancer. Jpn J Clin Oncol 21:120-124
20. Petrelli N, Douglas HO Jr, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Schinella R, Green MD, Mugga FM (1989) The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 7:1419-1426
21. Pyrhoenen S, Kuritunen T, Nyandoto P, Kouri M (1995) Randomized comparison of fluorouracil, epidoxorubicin, and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587-591
22. Shirao K, Shimada Y, Kondoh H, Saito D, Yamao T, Ono H, Yokoyama T, Fukuda H, Oka M, Watanabe Y, Ohtsu A, Boku N, Fujii T, Oda Y, Miro K, Yoshida Y (1997) Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer. J Clin Oncol 15:921-927
23. Stephens FO, Adams BG, Crea P (1986) Intra-arterial chemotherapy given preoperatively in the management of carcinoma of the stomach. Surg Gynecol Obstet 162:370-374
24. Wilke SH, Preuseer P, Fink U, Achterrath W, Meyer HJ, Stahl M, Lenas L, Meyer J, Siewert JR, Geerlings H, Koehne-Woempner CH, Harstrick A, Schmoll HJ (1990) New developments in the treatment of gastric carcinoma. Semin Oncol 17:61-70
25. Yoshida S, Shimada Y, Shirao K, Saito D (1992) Systemic chemotherapy against metastatic gastric cancer: recent advance and future directions. Cancer Res Clin 1:34-41